Cargando…
Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802109/ https://www.ncbi.nlm.nih.gov/pubmed/36588674 http://dx.doi.org/10.3389/fphar.2022.1117317 |
| _version_ | 1784861621944844288 |
|---|---|
| author | Huang, Guirui Huang, Shuaiyang Cui, Hongsheng |
| author_facet | Huang, Guirui Huang, Shuaiyang Cui, Hongsheng |
| author_sort | Huang, Guirui |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9802109 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98021092022-12-31 Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis Huang, Guirui Huang, Shuaiyang Cui, Hongsheng Front Pharmacol Pharmacology Frontiers Media S.A. 2022-12-16 /pmc/articles/PMC9802109/ /pubmed/36588674 http://dx.doi.org/10.3389/fphar.2022.1117317 Text en Copyright © 2022 Huang, Huang and Cui. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Huang, Guirui Huang, Shuaiyang Cui, Hongsheng Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis |
| title | Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis |
| title_full | Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis |
| title_fullStr | Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis |
| title_full_unstemmed | Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis |
| title_short | Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis |
| title_sort | corrigendum: effect of m6a regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802109/ https://www.ncbi.nlm.nih.gov/pubmed/36588674 http://dx.doi.org/10.3389/fphar.2022.1117317 |
| work_keys_str_mv | AT huangguirui corrigendumeffectofm6aregulatorsondiagnosissubtypeclassificationprognosisandnoveltherapeutictargetdevelopmentofidiopathicpulmonaryfibrosis AT huangshuaiyang corrigendumeffectofm6aregulatorsondiagnosissubtypeclassificationprognosisandnoveltherapeutictargetdevelopmentofidiopathicpulmonaryfibrosis AT cuihongsheng corrigendumeffectofm6aregulatorsondiagnosissubtypeclassificationprognosisandnoveltherapeutictargetdevelopmentofidiopathicpulmonaryfibrosis |